The Asia Pacific Postpartum Hemorrhage (PPH) Devices Market is expected to witness market growth of 5.7% CAGR during the forecast period (2022-2028).
The rising number of maternal mortalities has fueled the demand for sophisticated treatments and equipment to ensure that pregnancy-related problems are effectively treated. The market for postpartum hemorrhage (PPH) treatment devices is predicted to grow significantly as a result of the factor. While producers of these devices have discovered profitable opportunities in rich countries, they have yet to establish a foothold in developing and underdeveloped nations.
Increased pregnancy difficulties, such as large size babies, inverted uterus, and multiple pregnancies, are a crucial reason driving the postpartum hemorrhage devices' market expansion. Furthermore, an increase in postpartum hemorrhage risk factors such as uterine atony and trauma, as well as an increase in anemia instances in pregnant women and increased awareness about PPH risk factors, all contribute to the market's growth.
In India, the sample registration scheme (SRS) revealed that PPH was a prominent cause of maternal mortality, accounting for 30% of maternal deaths in the 1998 survey of causes of death and that postpartum hemorrhages account for 38% of maternal fatalities in the 2001-2003 SRS. The Indian Council of Medical Research (ICMR) estimated the maternal mortality ratio in India in 2003 and found postpartum hemorrhage to be the primary cause of maternal mortality in the studied population.
In Kolkata, West Bengal, India, a prospective observational study was conducted over a one-year period in a tertiary-level referral institute. All PPH cases were discovered and investigated. The Chi-square test was used to analyze the data. PPH was revealed to be the causal cause in 79 (37.6%) of 210 cases of maternal morbidity. Uterine atonicity was discovered to be the primary cause of PPH in 45 instances (56.9%). Severe PPH was identified in 34.3 percent of vaginally delivered patients and 60 percent of operatively delivered patients, which was statistically significant. Outside the medical college, 17/31 (54.8 percent) of severe PPH cases were delivered. Thus, the reasonably high rate of postpartum incidences in the country is likely to lead to the rise in demand for postpartum hemorrhage devices.
The China market dominated the Asia Pacific Postpartum Hemorrhage (PPH) Devices Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $83.2 Million by 2028. The Japan market is poised to grow at a CAGR of 5.1% during (2022 - 2028). Additionally, The India market is expected to witness a CAGR of 6.4% during (2022 - 2028).
Based on Product, the market is segmented into Uterine Tamponade Devices, Prefilled Injection System, and Non-Pneumatic Anti-Shock Garment. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teleflex, Inc., Becton, Dickinson and Company, Bactiguard Holding AB, Utah Medical Products, Inc., Organon & Co., Cook Medical, Inc., PATH, Obstetrx, Inc., Zoex Corporation, and 3rd Stone Design, Inc.
The rising number of maternal mortalities has fueled the demand for sophisticated treatments and equipment to ensure that pregnancy-related problems are effectively treated. The market for postpartum hemorrhage (PPH) treatment devices is predicted to grow significantly as a result of the factor. While producers of these devices have discovered profitable opportunities in rich countries, they have yet to establish a foothold in developing and underdeveloped nations.
Increased pregnancy difficulties, such as large size babies, inverted uterus, and multiple pregnancies, are a crucial reason driving the postpartum hemorrhage devices' market expansion. Furthermore, an increase in postpartum hemorrhage risk factors such as uterine atony and trauma, as well as an increase in anemia instances in pregnant women and increased awareness about PPH risk factors, all contribute to the market's growth.
In India, the sample registration scheme (SRS) revealed that PPH was a prominent cause of maternal mortality, accounting for 30% of maternal deaths in the 1998 survey of causes of death and that postpartum hemorrhages account for 38% of maternal fatalities in the 2001-2003 SRS. The Indian Council of Medical Research (ICMR) estimated the maternal mortality ratio in India in 2003 and found postpartum hemorrhage to be the primary cause of maternal mortality in the studied population.
In Kolkata, West Bengal, India, a prospective observational study was conducted over a one-year period in a tertiary-level referral institute. All PPH cases were discovered and investigated. The Chi-square test was used to analyze the data. PPH was revealed to be the causal cause in 79 (37.6%) of 210 cases of maternal morbidity. Uterine atonicity was discovered to be the primary cause of PPH in 45 instances (56.9%). Severe PPH was identified in 34.3 percent of vaginally delivered patients and 60 percent of operatively delivered patients, which was statistically significant. Outside the medical college, 17/31 (54.8 percent) of severe PPH cases were delivered. Thus, the reasonably high rate of postpartum incidences in the country is likely to lead to the rise in demand for postpartum hemorrhage devices.
The China market dominated the Asia Pacific Postpartum Hemorrhage (PPH) Devices Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $83.2 Million by 2028. The Japan market is poised to grow at a CAGR of 5.1% during (2022 - 2028). Additionally, The India market is expected to witness a CAGR of 6.4% during (2022 - 2028).
Based on Product, the market is segmented into Uterine Tamponade Devices, Prefilled Injection System, and Non-Pneumatic Anti-Shock Garment. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teleflex, Inc., Becton, Dickinson and Company, Bactiguard Holding AB, Utah Medical Products, Inc., Organon & Co., Cook Medical, Inc., PATH, Obstetrx, Inc., Zoex Corporation, and 3rd Stone Design, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Uterine Tamponade Devices
- Prefilled Injection System
- Non-Pneumatic Anti-Shock Garment
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Teleflex, Inc.
- Becton, Dickinson and Company
- Bactiguard Holding AB
- Utah Medical Products, Inc.
- Organon & Co.
- Cook Medical, Inc.
- PATH
- Obstetrx, Inc.
- Zoex Corporation
- 3rd Stone Design, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Asia Pacific Postpartum Hemorrhage (PPH) Devices Market by Product
Chapter 4. Asia Pacific Postpartum Hemorrhage (PPH) Devices Market by Country
Chapter 5. Company Profiles
Companies Mentioned
- Teleflex, Inc.
- Becton, Dickinson and Company
- Bactiguard Holding AB
- Utah Medical Products, Inc.
- Organon & Co.
- Cook Medical, Inc.
- PATH
- Obstetrx, Inc.
- Zoex Corporation
- 3rd Stone Design, Inc.
Methodology
LOADING...
